Items tagged with Drug-resistant TB
MSF calls on Johnson & Johnson to lower price of lifesaving TB drug (post with simple image)
Group protests at New York Stock Exchange as Johnson & Johnson releases earnings report.
WHO urges countries to enable access to fully-oral drug-resistant TB treatment regimens (post with simple image)
WHO releases updated guidelines for the treatment of drug-resistant TB.
Stop TB Partnership and Johnson & Johnson announce price reduction for bedaquiline (post with simple image)
Stop TB Partnership and Johnson & Johnson, with support from USAID and the Global Fund, announce price reduction for bedaquiline for treatment of drug-resistant TB in low- and middle-income countries.
Johnson & Johnson TB drug price reduction is important step, and governments need to urgently scale up better treatment (post with simple image)
120,707 people signed petitions urging the corporation to drop the price.
Treatment Action Group statement on bedaquiline unaffordability (post with simple image)
Bedaquiline is a public good, and must be treated as such. Johnson & Johnson once again refused to meet evidence-based demands to price bedaquiline at $1/day.
TB CAB Statement (post with simple image)
TB CAB Access Considerations Statement Regarding Johnson & Johnson Announcement of Bedaquiline Price Reduction
TAG launches two new TB Activist Guides (post with simple image)
Treatment Action Group launches two new TB Activist Guides: An Activist’s Guide to Tuberculosis Diagnostic Tools, and An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis.
TB REACH Wave 9 now open for proposals (post with simple image)
Wave 9 to address shortcomings in drug-resistant TB care - linkage to care, uptake of novel treatment regimens and treatment outcomes.
Page 95 of 95 · Total posts: 0←First 94 95